• BrainStorm Announces NurOwn Expanded Access Program americanpharmaceuticalreview
    January 05, 2021
    BrainStorm Cell Therapeutics has announced the initiation of a NurOwn® (MSC-NTF cells) Expanded Access Program (EAP) for patients with amyotrophic lateral sclerosis (ALS) who completed the Company's recently concluded pivotal Phase 3 clinical trial ...
PharmaSources Customer Service